Cutler Group LP Pulse Biosciences, Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$6.23 - $13.09 $623 - $1,309	-100 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$11.11 - $17.34 $1,111 - $1,734	-100 Reduced 50.0%	100 $1,000
Q2 2018 Aug 10, 2018	SELL	$14.04 - $20.28 $7,020 - $10,140	-500 Reduced 71.43%	200 $3,000
Q4 2017 Jan 17, 2018	BUY	$18.81 - $30.33 $1,880 - $3,033	100 Added 16.67%	700 $16,000
Q3 2017 Oct 17, 2017	BUY	$10.26 - $24.97 $6,156 - $14,982	600	600 $11,000

4.8M

138K

96.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.